Email News
FDA Approves Convalescence Plasma Treatment For COVID-19 Patients
The Food and Drugs Authority (FDA) has approved an investigational convalescent plasma collected from individuals who have recovered from COVID-19 for the treatment of critically ill COVID-19 patients.
Recipient Email:
*
Your name:
*
Your Email:
*